Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system

Contraception

Volumn 92, Issue 1, 2015, Pages 10-16

  Eisenberg, David L ^a   Schreiber, Courtney A ^b   Turok, David K ^c   Teal, Stephanie B ^d   Westhoff, Carolyn L ^e   Creinin, Mitchell D ^f  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Contraception; Intrauterine device; Levonorgestrel; Liletta

Indexed keywords

LEVONORGESTREL; CONTRACEPTIVE AGENT;

ABDOMINAL DISCOMFORT; ACNE; ADOLESCENT; ADULT; ARTICLE; BODY MASS; COMPARATIVE STUDY; CONTRACEPTIVE BEHAVIOR; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; DYSPAREUNIA; ENDOMETRITIS; FEMALE; FOLLOW UP; HEADACHE; HUMAN; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; MAJOR CLINICAL STUDY; MASTALGIA; MEDICAL HISTORY; MOOD DISORDER; NAUSEA; NULLIPARA; OVARY CYST; PELVIC INFLAMMATORY DISEASE; PELVIC PAIN; PREGNANCY; PREGNANCY RATE; PREGNANCY TEST; RISK ASSESSMENT; TRANSVAGINAL ECHOGRAPHY; TREATMENT DURATION; UTERUS BLEEDING; UTERUS PERFORATION; VAGINITIS; VOMITING; ADVERSE EFFECTS; CONTRACEPTION; INTRAUTERINE CONTRACEPTIVE DEVICE; INTRAUTERINE DEVICE EXPULSION; MIDDLE AGED; PARITY; PELVIC INFECTION; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; TIME FACTOR; UTERINE HEMORRHAGE; YOUNG ADULT;

ADOLESCENT; ADULT; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HUMANS; INTRAUTERINE DEVICE EXPULSION; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; MIDDLE AGED; PARITY; PELVIC INFECTION; PREGNANCY; PREGNANCY RATE; TIME FACTORS; UTERINE HEMORRHAGE; YOUNG ADULT;

EID: 84932196777     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2015.04.006     Document Type: Article

References (23)

1. L.B. Finer, and M.R. Zolna Shifts in intended and unintended pregnancies in the United States, 2001-2008 Am J Public Health 104 2014 S43 S48 [Suppl.]
2. B. Winner, J.F. Peipert, Q. Zhao, C. Buckel, T. Madden, J.E. Allsworth, and et al. Effectiveness of long-acting reversible contraception N Engl J Med 366 2012 1998 2007
3. ESHRE Capri Workshop Group Intrauterine devices and intrauterine systems Hum Reprod Update 14 2008 197 208
4. L.B. Finer, J. Jerman, and M.L. Kavanaugh Changes in use of long-acting contraceptive methods in the United States, 2007-2009 Fertil Steril 98 2012 893 897
5. R.A. Hatcher, J. Trussell, A.L. Nelson, W. Cates, D. Kowal, and M. Policar Contraceptive technology: twentieth revised edition 2011 Ardent Media New York NY
6. K. Andersson, I. Batar, and G. Rybo Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-T Contraception 46 1992 575 584
7. H. Belhadj, I. Sivin, S. Diaz, M. Pavez, A.S. Tejada, V. Brache, and et al. Recovery of fertility after use of the levonorgestrel 20 mcg/d or copper T 380Ag intrauterine device Contraception 34 1986 261 267
8. I. Sivin, J. Stern, S. Diaz, M. Pavéz, F. Alvarez, V. Brache, and et al. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper Tcu 380Ag intrauterine contraceptive devices Am J Obstet Gynecol 166 1992 1208 1213
9. J. Yoost Understanding benefits and addressing misperceptions and barriers to intrauterine device access among populations in the United States Patient Prefer Adherence 8 2014 947 957
10. L.B. Finer, and M.R. Zolna Unintended pregnancy in the United States: incidence and disparities, 2006 Contraception 84 2011 478 485
11. C. Dehlendorf, M.I. Rodriguez, K. Levy, S. Borrero, and J. Steinauer Disparities in family planning Am J Obstet Gynecol 202 2010 214 220
12. T.C. Wright Jr., L.S. Massad, C.J. Dunton, M. Spitzer, E.J. Wilkinson, and D. Solomon 2006 consensus guidelines for the management of women with abnormal cervical screening tests J Low Genit Tract Dis 11 2007 201 222
13. Centers for Disease Control and Prevention Sexually transmitted diseases treatment guidelines MMWR 59 No. RR-12 2010
14. Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, and Centers for Disease Control and Prevention (CDC) U.S. Selected Practice Recommendations for Contraceptive Use, 2013: adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition MMWR Recomm Rep 62 RR-05 2013 1 60
15. K.R. Humes, N.A. Jones, and R.R. Ramirez Overview of race and Hispanic origin: 2010 2011 U.S. Census Bureau Washington, DC [Accessed February 6, 2015 at http://www.census.gov/prod/cen2010/briefs/c2010br-02.pdf ]
16. J.T. Jensen, A.L. Nelson, and A.C. Costales Subject and clinician experience with the levonorgestrel-releasing intrauterine system Contraception 77 2008 22 29
17. K. Andersson, V. Odlind, and G. Rybo Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial Contraception 49 1994 56 72
18. B. Kaneshiro, and T. Aeby Long-term safety, efficacy, and patient acceptability of the intrauterine Copper T-380A contraceptive device Int J Womens Health 2 2010 211 220
19. M. Mawet, F. Nollevaux, D. Nizet, F. Wijzen, V. Gordenne, N. Tasev, and et al. Impact of a new levonorgestrel intrauterine system, Levosert(®), on heavy menstrual bleeding: results of a one-year randomised controlled trial Eur J Contracept Reprod Health Care 19 2014 169 179
20. T. Madden, C. McNicholas, Q. Zhao, G.M. Secura, D.L. Eisenberg, and J.F. Peipert Association of age and parity with intrauterine device expulsion Obstet Gynecol 124 2014 718 726
21. C.B. Sufrin, D. Postlethwaite, M.A. Armstrong, M. Merchant, J.M. Wendt, and J.E. Steinauer Neisseria gonorrhea and chlamydia trachomatis screening at intrauterine device insertion and pelvic inflammatory disease Obstet Gynecol 120 2012 1314 1321
22. T.M. Farley, M.J. Rosenberg, P.J. Rowe, J.H. Chen, and O. Meirik Intrauterine devices and pelvic inflammatory disease: an international perspective Lancet 339 1992 785 788
23. P. Inki, R. Hurskainen, P. Palo, E. Ekholm, S. Grenman, A. Kivela, and et al. Comparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system vs. hysterectomy Ultrasound Obstet Gynecol 20 2002 381 385